Cargando…

Simulating the Potential of Model-Based Individualized Prescriptions for Ultracentral Lung Tumors

PURPOSE: The use of stereotactic body radiation therapy for ultracentral lung tumors is limited by increased toxicity. We hypothesized that using published normal tissue complication probability (NTCP) and tumor control probability (TCP) models could improve the therapeutic ratio between tumor contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ishita, Iyer, Aditi, Thor, Maria, Wu, Abraham J., Apte, Aditya, Rimner, Andreas, Gomez, Daniel, Deasy, Joseph O., Jackson, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692285/ https://www.ncbi.nlm.nih.gov/pubmed/38047220 http://dx.doi.org/10.1016/j.adro.2023.101285

Ejemplares similares

External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors
por: Chen, Ishita, et al.
Publicado: (2022)

Cardio-pulmonary substructure segmentation of radiotherapy computed tomography images using convolutional neural networks for clinical outcomes analysis
por: Haq, Rabia, et al.
Publicado: (2020)

Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer
por: Hotca, Alexandra, et al.
Publicado: (2019)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease
por: Schiff, Joshua P., et al.
Publicado: (2023)

Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
por: Cella, Laura, et al.
Publicado: (2021)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
por: von Reibnitz, Donata, et al.
Publicado: (2020)

Registering Study Analysis Plans (SAPs) Before Dissecting Your Data—Updating and Standardizing Outcome Modeling
por: Thor, Maria, et al.
Publicado: (2020)

Simulating intrafraction prostate motion with a random walk model
por: Pommer, Tobias, et al.
Publicado: (2017)

Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence
por: Davey, Angela, et al.
Publicado: (2023)

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
por: Yang, Dan, et al.
Publicado: (2020)

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
por: Zhao, Yizhou, et al.
Publicado: (2020)

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)
por: Regnery, Sebastian, et al.
Publicado: (2022)

Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity
por: Rock, Crosby, et al.
Publicado: (2023)

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer
por: Luo, Leo Y., et al.
Publicado: (2020)

Four-Dimensional Computed Tomography-Based Correlation of Respiratory Motion of Lung Tumors With Implanted Fiducials and an External Surrogate
por: Willmann, Jonas, et al.
Publicado: (2021)

Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome
por: Farrugia, Mark, et al.
Publicado: (2021)

A corrective prescription for GISAXS
por: Strzalka, Joseph
Publicado: (2018)

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab
por: Shaverdian, Narek, et al.
Publicado: (2020)

Dose-response relationship of stereotactic body radiotherapy for ultracentral tumor and comparison of efficacy with central tumor: a meta-analysis
por: Rim, Chai Hong, et al.
Publicado: (2020)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
por: Sandoval, Maria L., et al.
Publicado: (2023)

Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone
por: Tixier, Florent, et al.
Publicado: (2019)

Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer
por: Haseltine, Justin M., et al.
Publicado: (2023)

Diffusion‐weighted MRI of the lung at 3T evaluated using echo‐planar‐based and single‐shot turbo spin‐echo‐based acquisition techniques for radiotherapy applications
por: Tyagi, Neelam, et al.
Publicado: (2018)

Unpaired Cross-Modality Educed Distillation (CMEDL) for Medical Image Segmentation
por: Jiang, Jue, et al.
Publicado: (2022)

Enhanced super‐resolution reconstruction of T1w time‐resolved 4DMRI in low‐contrast tissue using 2‐step hybrid deformable image registration
por: Nie, Xingyu, et al.
Publicado: (2020)

Enhancement of Long-Term External–Internal Correlation by Phase-Shift Detection and Correction Based on Concurrent External Bellows and Internal Navigator Signals
por: Milewski, Andrew R., et al.
Publicado: (2019)

Deep learning auto-segmentation and automated treatment planning for trismus risk reduction in head and neck cancer radiotherapy
por: Thor, Maria, et al.
Publicado: (2021)

A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients
por: Oberije, Cary, et al.
Publicado: (2015)

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial
por: Henke, Lauren E., et al.
Publicado: (2018)

Dual‐input tracer kinetic modeling of dynamic contrast‐enhanced MRI in thoracic malignancies
por: Lee, Sang Ho, et al.
Publicado: (2019)

Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer
por: Montovano, Margaret, et al.
Publicado: (2021)

Clinical Experience of Automated SBRT Paraspinal and Other Metastatic Tumor Planning With Constrained Hierarchical Optimization
por: Hong, Linda, et al.
Publicado: (2019)

A multidisciplinary intervention to improve safety of antidiabetic prescriptions
por: Rodríguez Ramallo, Héctor, et al.
Publicado: (2021)

Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non‐small cell lung cancer radiotherapy
por: Yorke, Ellen D., et al.
Publicado: (2021)

Independent test of a model to predict severe acute esophagitis
por: Huang, Ellen X., et al.
Publicado: (2016)

Interval From Simulation Imaging to Treatment Delivery in SABR of Lung Lesions: How Long is Too Long for the Lung?
por: Colin, Gilles, et al.
Publicado: (2022)

Reproducibility of radiomic features using network analysis and its application in Wasserstein k-means clustering
por: Oh, Jung Hun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rl06h4eo0a53oebtr65a7ld8g